Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

Vasogen CHF Immune Therapy Succeeds In Phase II CHF Study

March 1, 2002

Amgen Ends Deal With Bioject On Needle-Free Delivery Systems

Feb. 28, 2002

Amgen Ends Deal With Bioject On Needle-Free Delivery Systems

Feb. 28, 2002

Paradigm Enters MetaVantage Alliance With VDDI, Fires CEO

Feb. 27, 2002

Paradigm Enters MetaVantage Alliance With VDDI, Fires CEO

Feb. 27, 2002

Confirmant Unveils Protein Atlas Database For Drug Discovery

Feb. 26, 2002

Angiotech Comes Up Short In Phase II Multiple Sclerosis Study

Feb. 26, 2002

Confirmant Unveils Protein Atlas Database For Drug Discovery

Feb. 26, 2002

Angiotech Comes Up Short In Phase II Multiple Sclerosis Study

Feb. 26, 2002

Restoragen Cuts Half Its Staff, Plans To Rework Business Plan

Feb. 25, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...